These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24498265)
21. CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor in a 60-year-old patient with attributes of the Ewing family of neoplasms. Sezer O; Jugovic D; Blohmer JU; Turzynski A; Thiel G; Langelotz C; Possinger K; Kovar H Diagn Mol Pathol; 1999 Sep; 8(3):120-4. PubMed ID: 10565682 [TBL] [Abstract][Full Text] [Related]
25. iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma. Ishii M; Ando J; Yamazaki S; Toyota T; Ohara K; Furukawa Y; Suehara Y; Nakanishi M; Nakashima K; Ohshima K; Nakauchi H; Ando M Cancer Immunol Res; 2021 Oct; 9(10):1175-1186. PubMed ID: 34385178 [TBL] [Abstract][Full Text] [Related]
26. EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Robin TP; Smith A; McKinsey E; Reaves L; Jedlicka P; Ford HL Mol Cancer Res; 2012 Aug; 10(8):1098-108. PubMed ID: 22723308 [TBL] [Abstract][Full Text] [Related]
27. EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma. Katschnig AM; Kauer MO; Schwentner R; Tomazou EM; Mutz CN; Linder M; Sibilia M; Alonso J; Aryee DNT; Kovar H Oncogene; 2017 Oct; 36(43):5995-6005. PubMed ID: 28671673 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma. Wei E; Mitanoska A; O'Brien Q; Porter K; Molina M; Ahsan H; Jung U; Mills L; Kyba M; Bosnakovski D Mol Cancer; 2024 Oct; 23(1):222. PubMed ID: 39367409 [TBL] [Abstract][Full Text] [Related]
29. FOXM1 is an oncogenic mediator in Ewing Sarcoma. Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673 [TBL] [Abstract][Full Text] [Related]
30. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923 [TBL] [Abstract][Full Text] [Related]
31. ETS1, a Target Gene of the EWSR1::FLI1 Fusion Oncoprotein, Regulates the Expression of the Focal Adhesion Protein TENSIN3. Ebegboni VJ; Jones TL; Brownmiller T; Zhao PX; Pehrsson EC; Sundara Rajan S; Caplen NJ Mol Cancer Res; 2024 Jul; 22(7):625-641. PubMed ID: 38588446 [TBL] [Abstract][Full Text] [Related]
32. EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model. González I; Vicent S; de Alava E; Lecanda F J Mol Med (Berl); 2007 Sep; 85(9):1015-29. PubMed ID: 17453169 [TBL] [Abstract][Full Text] [Related]
33. SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth. Su S; Chen J; Jiang Y; Wang Y; Vital T; Zhang J; Laggner C; Nguyen KT; Zhu Z; Prevatte AW; Barker NK; Herring LE; Davis IJ; Liu P Adv Sci (Weinh); 2021 Jul; 8(14):e2004846. PubMed ID: 34060252 [TBL] [Abstract][Full Text] [Related]
34. ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. Gao Y; He XY; Wu XS; Huang YH; Toneyan S; Ha T; Ipsaro JJ; Koo PK; Joshua-Tor L; Bailey KM; Egeblad M; Vakoc CR Nat Cell Biol; 2023 Feb; 25(2):298-308. PubMed ID: 36658219 [TBL] [Abstract][Full Text] [Related]
40. Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines. Embree LJ; Azuma M; Hickstein DD Cancer Res; 2009 May; 69(10):4363-71. PubMed ID: 19417137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]